immune therapy
Showing 1 - 25 of >10,000
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)
Active, not recruiting
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
-
Rozzano, Milano, ItalyIstituto Clinico Humanitas
May 17, 2023
Lung Cancer Stage IV Trial in Maastricht (Radiation)
Not yet recruiting
- Lung Cancer Stage IV
- Radiation
-
Maastricht, NetherlandsMaastricht Radiation Oncology (Maastro)
Aug 29, 2023
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Gemtuzumab Ozogamicin
-
Valhalla, New YorkNew York Medical College
Sep 26, 2022
Intrahepatic Cholangiocarcinoma Trial (Transcatheter arterial chemoembolization, Multi-target Drug Therapy, Immunocheckpoint
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Transcatheter arterial chemoembolization
- +3 more
- (no location specified)
Feb 17, 2022
Lung Cancer, NSCLC Trial in Tampa (Vorinostat, Pembrolizumab)
Active, not recruiting
- Lung Cancer
- Non-small Cell Lung Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022
HIV Infection Trial in Italy, Netherlands, Spain (Analytical Treatment Interruption + bNAbs infusion)
Withdrawn
- HIV Infection
- Analytical Treatment Interruption + bNAbs infusion
-
Milan, Lombardy, Italy
- +3 more
Aug 2, 2022
Recovery From Acute Immune Failure in Septic Shock by Immune
Recruiting
- Severe Sepsis
-
Magdeburg, Germany
- +1 more
Nov 20, 2023
Breast Cancer, Metastatic Cancer Trial (SHR-1316, SHR6390, Nab paclitaxel)
Not yet recruiting
- Breast Cancer
- Metastatic Cancer
- SHR-1316
- +4 more
- (no location specified)
Jan 11, 2022
Covid-19 Patients Trial in Giza (Cupping therapy with convential medical treatment, Convential medical treatment)
Completed
- Covid-19 Patients
- Cupping therapy with convential medical treatment
- Convential medical treatment
-
Giza, EgyptFaculty of physical therapy
Jun 11, 2023
Immune System Disorder Trial in Giza (Aerobic training, diet protocol)
Recruiting
- Immune System Disorder
- Aerobic training
- diet protocol
-
Giza, EgyptFaculty of Physical therapy, Cairo University
Nov 20, 2023
Immune Checkpoint Inhibitor Monotherapy or Combined With
Not yet recruiting
- Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
- Immune checkpoint inhibitor
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
Jan 30, 2023
Actinic Keratosis, Photodynamic Therapy Trial in Fairborn (Celecoxib 200mg, Placebo)
Recruiting
- Actinic Keratosis
- Photodynamic Therapy
- Celecoxib 200mg
- Placebo
-
Fairborn, OhioWright State Physicians
Jan 9, 2023
Immune-related Adverse Events Refractory to Standard Therapy and
Recruiting
- Immune-related Adverse Event
- Extracorporeal photopheresis
- Other immunosuppressive or immunomodulatory drugs
-
Munich, GermanyLMU Klinikum Hauttumorzentrum
Jan 17, 2023
Adjuvant Immune Checkpoint Inhibitors in Postoperative
Recruiting
- Hepatocellular Carcinoma
- Immune Checkpoint Inhibitors Based Adjuvant therapy
-
Nanning, Guangxi, ChinaJian-Hong Zhong
Jan 18, 2023
Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,
Completed
- Gastrointestinal Tumor
- Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
- tislelizumab (BeiGene, China) combined with PD-1 inhibitor
-
Hangzhou, ChinaZhejiang Hospital
Sep 1, 2023
Immune-related Colitis, Colitis Trial in Minneapolis (RMT, Placebo)
Not yet recruiting
- Immune-related Colitis
- Colitis
- RMT
- Placebo
-
Minneapolis, MinnesotaUniversity of Minnesota
Feb 4, 2023
AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)
Recruiting
- AIDS Virus
- Disorder of Immune Reconstitution
- normal saline
- Mesenchymal stem cells
-
Jinan, Shandong, ChinaShandong Public Health Clinical Center
May 14, 2023
Immune Markers in Pediatric ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
- (no location specified)
Oct 17, 2023
Last Period Not Earlier Than 6 Months Ago Trial in Moscow (oral menopausal hormone therapy, transdermal menopausal hormone
Active, not recruiting
- Last Period Not Earlier Than 6 Months Ago
- oral menopausal hormone therapy
- transdermal menopausal hormone therapy
-
Moscow, Russian FederationFederal State Budget Institution Research Center for Obstetrics,
Jan 9, 2023
Pediatric Cancer Trial in Charlotte (Vaccine)
Recruiting
- Pediatric Cancer
- Vaccine
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 27, 2023
Breast Cancer Trial in New York (Cryoablation, Ipilimumab, Nivolumab)
Active, not recruiting
- Breast Cancer
- Cryoablation
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 1, 2022
Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Durvalumab
- Rintatolimod
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Jun 23, 2023
Healthcare Resource Utilization and Costs of Immune Checkpoint
Completed
- Melanoma
-
East Hanover, New JerseyNovartis
May 12, 2023
Determine Pro-Inflammatory Cytokine Kinetics During Immune
Not yet recruiting
- Non Small Cell Lung Cancer
- Melanoma
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jan 30, 2023
Sepsis, Severe Trial in Germany (ARTICE)
Recruiting
- Sepsis, Severe
- ARTICE
-
Braunschweig, Germany
- +3 more
Jul 29, 2022